DE69836226D1 - Ifn rezeptor 1 bindende proteine, dafür kodierende dna und verfahren zur regulierung der zellulären antwort auf interferone - Google Patents

Ifn rezeptor 1 bindende proteine, dafür kodierende dna und verfahren zur regulierung der zellulären antwort auf interferone

Info

Publication number
DE69836226D1
DE69836226D1 DE69836226T DE69836226T DE69836226D1 DE 69836226 D1 DE69836226 D1 DE 69836226D1 DE 69836226 T DE69836226 T DE 69836226T DE 69836226 T DE69836226 T DE 69836226T DE 69836226 D1 DE69836226 D1 DE 69836226D1
Authority
DE
Germany
Prior art keywords
interferone
regulating
binding proteins
ifn receptor
dna processing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69836226T
Other languages
English (en)
Other versions
DE69836226T2 (de
Inventor
Michel Revel
Carolina Abramovitch
E Chebath
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yeda Research and Development Co Ltd
Original Assignee
Yeda Research and Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research and Development Co Ltd filed Critical Yeda Research and Development Co Ltd
Publication of DE69836226D1 publication Critical patent/DE69836226D1/de
Application granted granted Critical
Publication of DE69836226T2 publication Critical patent/DE69836226T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
    • C12N9/1007—Methyltransferases (general) (2.1.1.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Transplantation (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69836226T 1997-01-15 1998-01-15 Ifn rezeptor 1 bindende proteine, dafür kodierende dna und verfahren zur regulierung der zellulären antwort auf interferone Expired - Lifetime DE69836226T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3563697P 1997-01-15 1997-01-15
US35636P 1997-01-15
PCT/US1998/000671 WO1998031796A1 (en) 1997-01-15 1998-01-15 Novel ifn receptor 1 binding proteins, dna encoding them, and methods of modulating cellular response to interferons

Publications (2)

Publication Number Publication Date
DE69836226D1 true DE69836226D1 (de) 2006-11-30
DE69836226T2 DE69836226T2 (de) 2007-02-01

Family

ID=21883894

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69836226T Expired - Lifetime DE69836226T2 (de) 1997-01-15 1998-01-15 Ifn rezeptor 1 bindende proteine, dafür kodierende dna und verfahren zur regulierung der zellulären antwort auf interferone

Country Status (20)

Country Link
US (1) US7264945B2 (de)
EP (1) EP1019500B1 (de)
JP (1) JP4614473B2 (de)
KR (2) KR100591988B1 (de)
CN (1) CN1212398C (de)
AT (1) ATE342972T1 (de)
AU (1) AU731206C (de)
BG (1) BG64829B1 (de)
BR (1) BR9806755A (de)
CA (1) CA2276111A1 (de)
CZ (1) CZ299096B6 (de)
DE (1) DE69836226T2 (de)
DK (1) DK1019500T3 (de)
EA (1) EA003250B1 (de)
EE (1) EE04819B1 (de)
ES (1) ES2275297T3 (de)
IL (2) IL130960A0 (de)
NO (1) NO326104B1 (de)
UA (1) UA75560C2 (de)
WO (1) WO1998031796A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020119129A1 (en) * 1997-01-15 2002-08-29 Yeda Research And Development Co. Ltd. Novel IFN receptor 1 binding proteins, DNA encoding them, and methods of modulating cellular response to interferons
AU2002359916A1 (en) * 2001-12-27 2003-07-15 Takeda Chemical Industries, Ltd. Preventives/remedies for cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4220759A1 (de) * 1992-06-24 1994-01-05 Inst Genbiologische Forschung DNA-Sequenzen für Oligosaccharid-Transporter, Plasmide, Bakterien und Pflanzen enthaltend einen Transporter sowie Verfahren zur Herstellung und Transformation von Hefestämmen zur Identifikation des Transporteers
IL107378A (en) * 1993-10-24 2005-05-17 Yeda Res & Dev SOLUBLE INTERFERON alpha-RECEPTOR, ITS PREPARATION AND USE
US6242587B1 (en) * 1996-10-02 2001-06-05 The University Of North Carolina At Chapel Hill DNA molecules encoding a calcium-integrin binding protein

Also Published As

Publication number Publication date
BG64829B1 (bg) 2006-05-31
JP4614473B2 (ja) 2011-01-19
BG103627A (en) 2000-04-28
NO993412L (no) 1999-07-09
EP1019500A4 (de) 2004-04-07
DK1019500T3 (da) 2007-02-19
BR9806755A (pt) 2000-03-14
ATE342972T1 (de) 2006-11-15
ES2275297T3 (es) 2007-06-01
US7264945B2 (en) 2007-09-04
EA199900663A1 (ru) 2000-02-28
WO1998031796A1 (en) 1998-07-23
WO1998031796A8 (en) 1999-05-20
IL130960A (en) 2008-03-20
EP1019500A2 (de) 2000-07-19
KR20000070181A (ko) 2000-11-25
AU5824098A (en) 1998-08-07
NO993412D0 (no) 1999-07-09
IL130960A0 (en) 2001-01-28
EP1019500B1 (de) 2006-10-18
UA75560C2 (en) 2006-05-15
CZ299096B6 (cs) 2008-04-23
CA2276111A1 (en) 1998-07-23
US20030176678A1 (en) 2003-09-18
KR20050046779A (ko) 2005-05-18
CN1243544A (zh) 2000-02-02
CN1212398C (zh) 2005-07-27
AU731206C (en) 2002-05-16
EA003250B1 (ru) 2003-02-27
CZ247199A3 (cs) 2000-01-12
DE69836226T2 (de) 2007-02-01
KR100591988B1 (ko) 2006-06-21
JP2001508306A (ja) 2001-06-26
NO326104B1 (no) 2008-09-22
AU731206B2 (en) 2001-03-29
EE04819B1 (et) 2007-04-16
EE9900272A (et) 2000-02-15
KR100799828B1 (ko) 2008-01-31

Similar Documents

Publication Publication Date Title
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
DE69418181D1 (de) Cytokine dämpfende substanzen
DE68929043D1 (de) Für androgen-rezeptor-protein kodierende dna
BR9507657A (pt) Proteina isolada e purificada de papilomavirus recombinante capsideos particulas semelhantes a virus processos a virus processos para produzir a proteina para tratar ou prevenir a infecçao por papilomavirus para produzir uma proteina de capsideo de papilomavirus recombinante montada em um capsideo ou particula semelhante a virus e para induzir uma resposta imune em um animal vertebrado composiçoes farmacêuticas kit para a detecçao de papilomavirus ou anticorpos para papilomavirus e sistema sinte
MY102472A (en) Preparation of funtional human urokinase proteins.
DE68925226D1 (de) Monoklonale Antikörper
DE69531958D1 (de) (1-3)-beta-d-glukon-bindungsprotein, antikörper der dieses protein erkennt undverwendung des proteins und antikörper
ATE327328T1 (de) Adipozyten-spezifische protein homologe
DE68925275D1 (de) Endotoxin-bindeprotein und dessen verwendung
DE69826493D1 (de) Ikk-alpha proteine, nukleinsäuren und verfahren
MX9702789A (es) Novedosas proteinas ligandos del dominio de la muerte del receptor tnf, e inhibidores de la union delos ligandos.
DE60037978D1 (de) Interferon ähnliche moleküle, und deren verwendungen
WO2001040313A3 (en) Feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
DE69534471D1 (de) Peptide, die fähig sind die sh3-domäne des gap-proteins zu binden, ihre kodierende dns, ihre zubereitung und verwendung
DE59508137D1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
DE69836226D1 (de) Ifn rezeptor 1 bindende proteine, dafür kodierende dna und verfahren zur regulierung der zellulären antwort auf interferone
FI950516A (fi) Interferoni-alfa/beta-sitojaproteiini, sen valmistus ja käyttö
TR199700842T1 (xx) �nsan DNase I Varyantlar�.
DK0811068T3 (da) Humane DNase I varianter
SE9604439D0 (sv) New receptor
RU94026276A (ru) Рецепторы интерлейкина-12 и антител
ATE103635T1 (de) Reg-gen und dadurch kodiertes protein.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition